Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Elevated levels of neutrophil related chemokine citrullinated histone H3, interleukin-8 and C-reaction protein in patients with immune checkpoint inhibitor therapy: predictive biomarkers for response to treatment

Fig. 2

Baseline levels of H3Cit, IL-8 and CRP between ICI responder and nonresponder patients. (A) The difference in the serum levels of H3Cit in the primary cohort (P < 0.001). (B) IHC of H3Cit expression between ICI responder and nonresponder in lung cancer. (C) The difference in the levels of IL-8 in the primary cohort (P < 0.001). (D) The difference in the serum levels of CRP in the primary cohort (P < 0.001)

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us